Diabetes & Endocrinology
To view all our activities on diabetes and endocrinology, please click here
INDIVIDUALIZING TYPE 2 DIABETES TREATMENT: APPLYING THE LATEST EVIDENCE IN CONSIDERATION OF PATIENT CHARACTERISTICS
A 2-hour, live satellite symposium will feature practical, evidence-based insights by recognized expert clinicians on how to implement guidelines for individualizing T2DM management, evaluate benefit/risk profiles of newer T2DM therapies, and assess effects of newer T2DM therapies on macrovascular (eg, atherosclerotic cardiovascular disease) and microvascular (eg, chronic kidney disease) outcomes. Included in the agenda are didactic lectures, interactive case studies, and a faculty Q&A session. The symposium will be enhanced by an audience response system feature, which allows attendees to interact with the faculty about their experiences managing patients with T2DM.
An individualized approach to management of type 2 diabetes mellitus (T2DM) may be the most likely tactic for achieving the best outcomes for any given T2DM patient, but it poses a challenge to clinicians with limited time and resources, especially given the ever-expanding armamentarium of antidiabetic drugs - including the incretin-based classes (GLP-1 receptor agonists and DPP-4 inhibitors), SGLT2 inhibitors, and combination agents. This CME-certified web monograph, which includes faculty audio clips and interactive questions, was designed to help guide appropriate treatment selection based on the T2DM patient's clinical characteristics, therapeutic goals, and patient's preference.
This activity expired for credit on August 13, 2016
TYPE 2 DIABETES TREATMENT FOR DIVERSE POPULATIONS: INTEGRATING NEW AND EMERGING AGENTS
This live CME symposium, held in conjunction with the American Diabetes Association 74th Scientific Sessions 2014, was developed for healthcare professionals actively involved in the management of patients with diabetes. The dynamic faculty discussion focused on the consequences of inadequate diabetes management as well as characteristics of the incretin-based therapies and SGLT2 inhibitors, including their extraglycemic effects. The enduring on-demand CME/CE webinar further advanced the educational impact and reach of the program.
This activity expired for credit on July 10, 2015
This live CME symposium, held in conjunction with the American Heart Association Scientific Sessions 2013, consisted of a dynamic discussion structured around didactic lectures and challenging real-world patient cases. The enduring on-demand webinar further advanced the educational impact and reach of the program. The initiative was designed to educate clinicians involved in the management of patients with diabetes on how to improve care by communicating the latest significant, comprehensive, evidence-based advances in the diagnosis and treatment of diabetes and to address the more important issue of diabetes with comorbid conditions such as CVD.
This activity expired for credit on January 14, 2015
A MEN'S HEALTH INITIATIVE: FOCUS ON MALE HYPOGONADISM AND TESTOSTERONE REPLACEMENT THERAPY
This enduring, CME-certified web monograph was branded by Urology ("The Gold Journal") and hosted on www.goldjournal.net. The web monograph was MEDLINE-indexed and distributed by Elsevier via email blasts, print and banner ads to their mix of Urology and Internal Medicine Journals. The webinar was followed by a live CME-certified satellite symposium, held in conjunction with the Southeast Section meeting of the AUA in March 2014.
This activity expired for credit on November 7, 2014